{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":2,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6bcb093c5c3f","filters":{"venue":"Hematology Meeting Reports (formerly Haematologica Reports)"}},"results":[{"id":"W1608548877","doi":"10.4081/hmr.v2i5.719","title":"Progress in the management of iron overload in erytrocyte disorders","year":2009,"lang":"en","type":"article","venue":"Hematology Meeting Reports (formerly Haematologica Reports)","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Deferasirox; Deferiprone; Medicine; Thalassemia; Chelation therapy; Deferoxamine; Regimen; Neutropenia; Beta thalassemia; Internal medicine; Blood transfusion; Anemia; Pediatrics; Toxicity","authors":[{"name":"Maria Domenica Cappellini","is_ca":false},{"name":"Elena Cassinerio","is_ca":false},{"name":"Laura Zanaboni","is_ca":false},{"name":"Giovanna Fabio","is_ca":false},{"name":"Paolo Pattoneri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007839992710516944,"gpt":0.2621874017306792,"spread":0.2543474090201622,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001321401,0.0006449626,0.0007538117,0.001102066,0.0003357884,0.001046964,0.0008946288,0.0008686474,0.003181094],"category_scores_gemma":[0.001594054,0.0001299258,0.0007537061,0.0007100858,0.0004803075,0.00107132,0.0008094843,0.002190313,0.001529714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005491072,"about_ca_system_score_gemma":0.001168676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084997,"about_ca_topic_score_gemma":0.001138345,"domain_scores_codex":[0.9994128,0.000171996,0.00009741668,0.00008447426,0.000174234,0.0000591176],"domain_scores_gemma":[0.9991732,0.0003000218,0.000145838,0.00004251076,0.0002219025,0.0001164663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000252008,0.0002913289,0.001219246,0.003439967,0.00007727556,0.0009045128,0.0001377661,0.0004109932,0.002261786,0.002795636,0.01285041,0.975359],"study_design_scores_gemma":[0.000224177,0.001198868,0.007011414,0.006325046,0.000377434,0.01244457,0.0003068061,0.001096389,0.003116062,0.006044424,0.9618005,0.00005429856],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003240574,0.9826853,0.003606278,0.004101255,0.000636065,0.00003751935,0.00004661849,0.0000619838,0.00558436],"genre_scores_gemma":[0.02931397,0.952585,0.009367956,0.002487403,0.003147132,0.00008073449,0.0002441267,0.00003058631,0.002743132],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003181094,"threshold_uncertainty_score":0.01064181,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1554065380","doi":"10.4081/hmr.v3i3.587","title":"Advanced Hodgkin’s lymphoma: doxorubicin, bleomycin, vinblastine, dacarbazine and beyond","year":2009,"lang":"en","type":"article","venue":"Hematology Meeting Reports (formerly Haematologica Reports)","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Vinblastine; Bleomycin; Internal medicine; Oncology; Nuclear medicine; Chemotherapy; Vincristine; Cyclophosphamide","authors":[{"name":"Volker Diehl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008444083112896697,"gpt":0.2554773388233663,"spread":0.2470332557104696,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006022425,0.0002376484,0.0002984478,0.0003794166,0.0001907637,0.0005555149,0.0001766628,0.0005650882,0.00544765],"category_scores_gemma":[0.0005173627,0.0001152698,0.0001634981,0.0003300165,0.0002131536,0.0005417471,0.0004274688,0.001182723,0.001815066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007868456,"about_ca_system_score_gemma":0.0005749418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002235773,"about_ca_topic_score_gemma":0.01093988,"domain_scores_codex":[0.9998273,0.00003545373,0.00002394131,0.00002386321,0.00006414852,0.0000253569],"domain_scores_gemma":[0.9998196,0.00003606032,0.00002588668,0.00001031317,0.00004898505,0.00005927429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006865595,0.0001697105,0.002104344,0.0007891046,0.00002850318,0.0004083863,0.00007032269,0.0001999976,0.002595478,0.003007871,0.1020914,0.8878482],"study_design_scores_gemma":[0.0001798287,0.0004845475,0.0107456,0.0005355798,0.00003520168,0.001100081,0.00002702174,0.00008026491,0.0007826702,0.0007082188,0.9853086,0.0000123842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.0407543,0.7423066,0.001358583,0.05262265,0.01021394,0.0002578685,0.001185647,0.0002839558,0.1510164],"genre_scores_gemma":[0.2042992,0.5657295,0.003220756,0.03353224,0.008323848,0.0002770539,0.00280784,0.00008483643,0.1817247],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.00544765,"threshold_uncertainty_score":0.01822424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}